Product catalogue

Excludes Private Label

View all products >

News & Events

Wockhardt hosts visit of the UK Prime Minister

Wockhardt, the global pharmaceutical and biotechnology major, today hosted a visit at its
Wrexham facility in North Wales of the Prime Minister of the United Kingdom, Mr Boris
Johnson.

The Prime Minister inspected Wockhardt’s fill finish production line and was accompanied
by local Wrexham conservative MP Sarah Atherton.

Our Latest News & Events >

News & Events

UK Government Announces Covid-19 Vaccination Contract Extension with Wockhardt

Wockhardt, the global pharmaceutical and biotechnology major today announced that it has been awarded a six-month extension of its agreement with the UK Government to fill-finish COVID-19 vaccines.  This expands the original agreement from 18 to 24 months i.e., until August 2022 and the manufacturing will continue to be undertaken at CP Pharmaceuticals, a subsidiary of Wockhardt based in Wrexham, North Wales.

Read more >

Our Products

Wockhardt UK specialises in the manufacture and supply of generic and branded medicines, with a constantly growing portfolio of over 250 product lines.

 

Our products cover many therapy areas including anticoagulation, pain management, anti-infectives, diabetes and antibiotics. They are available in a wide range of preparations, ranging from tablets, capsules and injections, through to liquid medicines, ointments and creams.

Read more >